Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy

By Huang Zhao-Hui   Hua Dong   Li Li-Hua   Zhu Jing-De  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 10, 2008-10 ,pp. : 1129-1134

Springer Publishing Company

Access to resources Recommend Favorite

DNA Repair Gene and MTHFR Gene Polymorphisms as Prognostic Markers in Locally Advanced Adenocarcinoma of the Esophagus or Stomach Treated with Cisplatin and 5-Fluorouracil-Based Neoadjuvant Chemotherapy

By Ott Katja  

Annals of Surgical Oncology, Vol. 18, Iss. 9, 2011-09 ,pp. : 2688-2698

Springer Publishing Company

Access to resources Recommend Favorite

Predictive markers for the response to 5-fluorouracil therapy in cancer cells: Constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based chemotherapy

By      

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 321-327

Spandidos Publications

Access to resources Recommend Favorite

Irinotecan, leucovorin and 5fluorouracil (modified FOLFIRI) as salvage chemotherapy for frail or elderly patients with advanced gastric cancer

By                      

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 751-754

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer

By            

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1309-1314

Spandidos Publications

Access to resources Recommend Favorite